Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome | Request PDF
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
CRISPR, the disruptor : Nature News & Comment
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
CRISPR gene editing - Wikipedia
:no_upscale()/cdn.vox-cdn.com/uploads/chorus_image/image/60457727/CRISPR_LEAD.0.jpg "CRISPR, one of the biggest science stories of the decade, explained - Vox")
CRISPR, one of the biggest science stories of the decade, explained - Vox
Untangling the CRISPR cancer scare
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
CRISPR: gene editing is just the beginning : Nature News & Comment
Focus on CRISPR tools and therapies | Nature Biotechnology
CRISPR-engineered T cells in patients with refractory cancer | Science
Kill Switch for CRISPR Could Make Gene Editing Safer - Scientific American
CRISPR, the disruptor : Nature News & Comment
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR-Cas 9 corrects genetic defects in mice
First CRISPR editing trial results assuage safety concerns
CRISPR-Edited Cells Linked to Cancer Risk in 2 Studies - Scientific American
First Trial of CRISPR-Edited T cells in Lung Cancer: Trends in Molecular Medicine
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
Is Crispr the Next Antibiotic? - The New York Times
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
